Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer

BACKGROUND: The DYNAMIC trial investigated the use of circulating tumor DNA (ctDNA) to guide adjuvant treatment decisions in stage II colon cancer. Despite the DYNAMIC trial’s assertion that a ctDNA-guided approach could minimize the use of adjuvant treatment without compromising recurrence-free sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivier, Timothée, Haslam, Alyson, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485976/
https://www.ncbi.nlm.nih.gov/pubmed/37679732
http://dx.doi.org/10.1186/s12916-023-03037-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485976/
https://www.ncbi.nlm.nih.gov/pubmed/37679732
http://dx.doi.org/10.1186/s12916-023-03037-9

Ejemplares similares